Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Panelists discuss the challenges patients face in accessing lupus nephritis treatment and the resources available to support ...

ONE year after being diagnosed with lupus at 21 and initially fearing that it meant an early end to her life, ‘lupus warrior’ ...

Researchers found that among those patients affected by autoimmune skin diseases such as dermatomyositis (DM) and cutaneous ...

Kezar Life Sciences said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and focus on the development of the drug in ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

Panelists discuss the considerations guiding treatment choices for lupus nephritis, such as drug interactions, patient characteristics, and steroid use, and how treatment approaches might differ ...

Doctors in Hangzhou, Zhejiang province, have successfully completed the world's largest clinical study of involving the use ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with ...